Idea principal
Among 60,298 UK Biobank participants followed for an average 9.1 years, those in the top third of Mediterranean diet adherence on the MEDAS score had a lower dementia risk than the bottom third (HR 0.77, 95% CI 0.65-0.91). A second diet score gave a similar but less certain result (HR 0.86, 95% CI 0.73-1.02), and as an observational study it cannot show that the diet itself lowers risk.
Study design
Estudio de cohorte
Reading basis
Published abstract
Reading focus
Association & confounding
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
Dementia prevention is a major public health priority, and evidence on the Mediterranean diet has been inconclusive, often from small cohorts with few dementia cases. The authors tested whether closer adherence to a Mediterranean diet is linked to lower dementia risk, and whether this depends on a person's genetic risk.
Población y método
Prospective cohort analysis of 60,298 UK Biobank participants followed for an average 9.1 years. Adherence to the Mediterranean diet was scored in two ways: the Mediterranean Diet Adherence Screener (MEDAS, continuous) and the Mediterranean diet Pyramid (PYRAMID) score. Cox proportional hazard models estimated the association with incident all-cause dementia, and the interaction between diet and polygenic risk for dementia was tested. The abstract does not list the adjustment variables or how diet was collected.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Higher adherence to the Mediterranean diet by the MEDAS score was associated with lower dementia risk: HR 0.77 (95% CI 0.65-0.91), highest versus lowest tertile.
- 2With the PYRAMID score the estimate was HR 0.86 (95% CI 0.73-1.02) for the same comparison. Its interval includes 1.0, so it is less certain.
- 3There was no significant interaction between either diet score and polygenic risk for dementia, which the authors take to mean the link did not depend on genetic risk.
Límites e incertidumbre
- 1The two diet scores gave different strengths of evidence, and the PYRAMID result is not clearly distinguishable from no effect.
- 2Diet is measured at one point in time in an observational cohort, so healthier people overall may both eat this way and avoid dementia; the abstract does not describe the confounders adjusted for.
- 3UK Biobank volunteers are generally healthier than the wider population, and the average follow-up of 9.1 years is short for a disease that develops over decades.
- 4This reading is based on the abstract only.
Relevancia práctica
A pattern rich in the foods the scores reward may go along with lower dementia risk, even for people with higher genetic risk, but this study cannot say that changing your diet will prevent dementia. It fits with general advice on healthy eating. If you are worried about memory or family history, talk to your clinician.
Tus datos
Food logs are the relevant personal data: you can note how often you eat vegetables, fruit, legumes, fish and olive oil, which are typical Mediterranean diet foods. Log consistently over weeks and compare your own pattern over time, as a single day or one logged meal says little.
Cómo interpretar la evidencia
Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
The identification of effective dementia prevention strategies is a major public health priority, due to the enormous and growing societal cost of this condition. Consumption of a Mediterranean diet (MedDiet) has been proposed to reduce dementia risk. However, current evidence is inconclusive and is typically derived from small cohorts with limited dementia cases. Additionally, few studies have explored the interaction between diet and genetic risk of dementia.
Methods
We used Cox proportional hazard regression models to explore the associations between MedDiet adherence, defined using two different scores (Mediterranean Diet Adherence Screener [MEDAS] continuous and Mediterranean diet Pyramid [PYRAMID] scores), and incident all-cause dementia risk in 60,298 participants from UK Biobank, followed for an average 9.1 years. The interaction between diet and polygenic risk for dementia was also tested.
Results
Higher MedDiet adherence was associated with lower dementia risk (MEDAS continuous: HR = 0.77, 95% CI = 0.65-0.91; PYRAMID: HR = 0.86, 95% CI = 0.73-1.02 for highest versus lowest tertiles). There was no significant interaction between MedDiet adherence defined by the MEDAS continuous and PYRAMID scores and polygenic risk for dementia.
Conclusions
Higher adherence to a MedDiet was associated with lower dementia risk, independent of genetic risk, underlining the importance of diet in dementia prevention interventions.
Fuentes y atribución
Mediterranean diet adherence is associated with lower dementia risk, independent of genetic predisposition: findings from the UK Biobank prospective cohort study.
Shannon OM, Ranson JM, Gregory S, Macpherson H, Milte C, Lentjes M, Mulligan A, McEvoy C, Griffiths A, Matu J, Hill TR, Adamson A, Siervo M, Minihane AM, Muniz-Tererra G, Ritchie C, Mathers JC, Llewellyn DJ, Stevenson E.
BMC medicine · 2023-03-14
DOI: 10.1186/s12916-023-02772-3 ↗PubMed · 36915130 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

